News
OXFD
--
0.00%
--
Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery SARS-CoV-2 Test
OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has entered into an extensive research collaboration with Public Health England (PHE), an executive
GlobeNewswire · 8h ago
Oxford Immunotec Joins Forces With Public Health England In Large Clinical Trial Utilizing T-Spot Discovery Coronavirus Test
Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 22, 2020 (GLOBE
Benzinga · 9h ago
Oxford Immunotec (OXFD) Reports Q2 Loss, Lags Revenue Estimates
Oxford Immunotec (OXFD) delivered earnings and revenue surprises of -428.57% and -4.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 13:55
Oxford Immunotec Sees Q3 Sales $18M-$19M vs $15M Estimate
Benzinga · 08/04 11:40
Oxford Immunotec Global Q2 EPS $(0.37) Misses $(0.30) Estimate, Sales $5.83M Beat $5.80M Estimate
Oxford Immunotec Global (NASDAQ:OXFD) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.30) by 23.33 percent. This is a 1950 percent decrease over earnings of $0.02 per
Benzinga · 08/04 11:40
Oxford Immunotec Reports Second Quarter 2020 Financial Results
* Second quarter revenue of $5.8 million, a decrease of 70% compared to prior year period, due to the impact of COVID-19 * Ended the quarter with approximately $165 million of cash and cash equivalents * Third quarter revenue estimated to be between $18 -
GlobeNewswire · 08/04 11:00
Earnings Preview: Oxford Immunotec (OXFD) Q2 Earnings Expected to Decline
Oxford Immunotec (OXFD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/28 16:33
Did Hedge Funds Make The Right Call On Oxford Immunotec Global PLC (OXFD) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which
Insider Monkey · 07/28 14:48
Oxford Immunotec Schedules Second Quarter 2020 Earnings Release and Conference Call for August 4, 2020
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 21, 2020 -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today.
GlobeNewswire · 07/21 13:15
Oxford Immunotec Announces Agreement With Stop TB Partnership
Benzinga · 07/20 13:17
Oxford Immunotec Announces Agreement with Stop TB Partnership - Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 20, 2020 -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), today announced that it has entered into a long-term.
GlobeNewswire · 07/20 13:15
Hedge Funds Have Never Been This Bullish On Oxford Immunotec Global (OXFD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These fi
Insider Monkey · 06/22 16:19
The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18)
Benzinga · 05/19 12:27
Oxford releases test that measures immune response to SARS-CoV-2
Seeking Alpha - Article · 05/19 10:43
Oxford Immunotec Global PLC's (OXFD) CEO Peter Wrighton-Smith on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/10 21:12
Soft outlook pressures Oxford Immunotec; shares down 10%
Oxford Immunotec Global PLC (OXFD -9.8%) is down, albeit on below-average volume, after releasing Q1 results that came in shy of expectations. The company
seekingalpha · 05/05 19:46
PTLA, TGTX, NCLH and HTZ among midday movers
Seeking Alpha - Article · 05/05 16:42
Oxford Immunotec Global EPS misses by $0.05, misses on revenue
Oxford Immunotec Global (NASDAQ:OXFD): Q1 GAAP EPS of -$0.20 misses by $0.05. Revenue of $13.91M (-5.9% Y/Y) misses by $0.09M. Press Release
seekingalpha · 05/05 16:09
Oxford Immunotec (OXFD) Reports Q1 Loss, Lags Revenue Estimates
Oxford Immunotec (OXFD) delivered earnings and revenue surprises of -185.71% and -1.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/05 13:15
Recap: Oxford Immunotec Global Q1 Earnings
Benzinga · 05/05 12:40